The IndependentGlaxo Third-Quarter Profit Beat EstimatesBusinessweekGlaxoSmithKline Plc (GSK), the U.K.'s biggest drugmaker, reported third-quarter earnings that beat analyst estimates, even as currency effects and sluggish sales of its respiratory drugs in the U.S. hurt profit. Profit excluding certain items fell 1 percent to 1.89 ...GSK sees first Ebola vaccine doses ready late this yearReutersGlaxo beats profit estimates, but U.S.